Charles Schwab’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $157M | Buy |
|
|||||
|
2025
Q2 | $135M | Buy |
|
|||||
|
2025
Q1 | $139M | Buy |
|
|||||
|
2024
Q4 | $149M | Buy |
|
|||||
|
2024
Q3 | $177M | Buy |
|
|||||
|
2024
Q2 | $209M | Buy |
|
|||||
|
2024
Q1 | $185M | Buy |
|
|||||
|
2023
Q4 | $220M | Buy |
|
|||||
|
2023
Q3 | $218M | Sell |
|
|||||
|
2023
Q2 | $242M | Buy |
|
|||||
|
2023
Q1 | $235M | Buy |
|
|||||
|
2022
Q4 | $232M | Buy |
|
|||||
|
2022
Q3 | $219M | Buy |
|
|||||
|
2022
Q2 | $161M | Buy |
|
|||||
|
2022
Q1 | $161M | Buy |
|
|||||
|
2021
Q4 | $178M | Buy |
|
|||||
|
2021
Q3 | $207M | Buy |
|
|||||
|
2021
Q2 | $251M | Buy |
|
|||||
|
2021
Q1 | $197M | Sell |
|
|||||
|
2020
Q4 | $174M | Sell |
|
|||||
|
2020
Q3 | $209M | Sell |
|
|||||
|
2020
Q2 | $221M | Sell |
|
|||||
|
2020
Q1 | $297M | Buy |
|
|||||
|
2019
Q4 | $277M | Sell |
|
|||||
|
2019
Q3 | $225M | Buy |
|
|||||
|
2019
Q2 | $218M | Buy |
|
|||||
|
2019
Q1 | $217M | Buy |
|
|||||
|
2018
Q4 | $274M | Buy |
|
|||||
|
2018
Q3 | $314M | Sell |
|
|||||
|
2018
Q2 | $267M | Buy |
|
|||||
|
2018
Q1 | $244M | Buy |
|
|||||
|
2017
Q4 | $265M | Buy |
|
|||||
|
2017
Q3 | $243M | Sell |
|
|||||
|
2017
Q2 | $217M | Sell |
|
|||||
|
2017
Q1 | $230M | Buy |
|
|||||
|
2016
Q4 | $221M | Buy |
|
|||||
|
2016
Q3 | $233M | Buy |
|
|||||
|
2016
Q2 | $157M | Buy |
|
|||||
|
2016
Q1 | $165M | Sell |
|
|||||
|
2015
Q4 | $195M | Sell |
|
|||||
|
2015
Q3 | $193M | Sell |
|
|||||
|
2015
Q2 | $286M | Buy |
|
|||||
|
2015
Q1 | $294M | Buy |
|
|||||
|
2014
Q4 | $225M | Buy |
|
|||||
|
2014
Q3 | $214M | Buy |
|
|||||
|
2014
Q2 | $193M | Sell |
|
|||||
|
2014
Q1 | $191M | Buy |
|
|||||
|
2013
Q4 | $168M | Buy |
|
|||||
|
2013
Q3 | $142M | Buy |
|
|||||
|
2013
Q2 | $111M | Buy |
|